Together with our previous observations that cognitively impaired mice and humans have naturally occurring reductions in Hp1bp3 levels, our data suggest reduced Hp1bp3 is a relevant driver of aging and AD‐related phenotypes. Here, HP1BP3 is linked to Alzheimer disease.